Improving access to sterile syringes and safe syringe disposal for injection drug users in methadone maintenance treatment

Journal of Substance Abuse Treatment

Volumn 31, Issue 1, 2006, Pages 51-57

  McNeely, Jennifer ^a   Arnsten, Julia H ^b   Gourevitch, Marc N ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS HIV; Drug treatment; Health promotion disease prevention; Substance abuse; Syringe exchange

Indexed keywords

METHADONE;

ADULT; ARTICLE; BEHAVIOR CHANGE; COHORT ANALYSIS; CONTROLLED STUDY; DISPOSABLE EQUIPMENT; DRUG ABUSE; DRUG USE; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; NEEDLE; OPIATE ADDICTION; PHARMACY; PREVALENCE; PRIORITY JOURNAL; PURCHASING; RISK REDUCTION; SAFETY; SUBSTANCE ABUSE; SYRINGE; TREATMENT DURATION; UNITED STATES;

ADULT; AGED; ATTITUDE OF HEALTH PERSONNEL; COMMUNITY HEALTH SERVICES; FEMALE; HEALTH BEHAVIOR; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MEDICAL WASTE DISPOSAL; METHADONE; MIDDLE AGED; NARCOTICS; STERILIZATION; SUBSTANCE ABUSE, INTRAVENOUS; SYRINGES;

EID: 33745240401     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2006.03.009     Document Type: Article

References (31)

1. Academy for Academic Development. Access to sterile syringes. June 2000. Available at (2004). www.cdc.gov/idu/facts/aed_idu_acc.htm Accessed March 9
2. Ball J.C., and Ross A. The effectiveness of methadone maintenance treatment (1991), Springer-Verlag, New York
3. Burris S., Welsh J., Ng M., Li M., and Ditzler A. State syringe and drug possession laws potentially influencing safe syringe disposal by injection drug users. Journal of the American Pharmaceutical Association 42 6 Suppl 2 (2002) S94-S98
4. Caplehorn J.R., Hartel D.M., and Irwig L. Measuring and comparing the attitudes and beliefs of staff working in New York methadone maintenance clinics. Substance Use and Misuse 32 (1997) 399-413
5. De Irala J., Bigelow C., McCusker J., Hindin R., and Zheng L. Reliability of self-reported human immunodeficiency virus risk behaviors in a residential drug treatment population. American Journal of Epidemiology 143 (1996) 725-732
6. Des Jarlais D.C., Friedman S.R., et al. Continuity and change within an HIV epidemic: Injecting drug users in New York City, 1984 through 1992. Journal of the American Medical Association 271 (1994) 121-127
7. Des Jarlais D.C., McKnight C., and Friedmann P. Legal syringe purchases by injection drug users, Brooklyn and Queens, New York City, 2000-2001. Journal of the American Pharmaceutical Association 42 6 Suppl 2 (2002) S73-S76
8. Des Jarlais D.C., Perlis T., et al. HIV incidence among injection drug users in New York City, 1990 to 2002. American Journal of Public Health 95 (2005) 1444-1493
9. Forman R.F., Bovasso G., and Woody G. Staff beliefs about addiction treatment. Journal of Substance Abuse Treatment 21 (2001) 1-9
10. Frank B. An overview of heroin trends in New York City: Past, present and future. Mount Sinai Journal of Medicine 67 (2000) 340-346
11. Fuller C.M., Ahern J., Vadnai L., Coffin P.O., Galea S., Factor S.H., et al. Impact of increased syringe access: Preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York. Journal of the American Pharmaceutical Association 42 6 Suppl 2 (2002) S77-S82
12. Gleghorn A.A., Jones T.S., Doherty M.C., Celentano D.D., and Vlahov D. Acquisition and use of needles and syringes in Baltimore, Maryland. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 10 (1995) 97-103
13. Gleghorn A.A., Wright-De Aguero L., and Flynn C. Feasibility of one-time use of sterile syringes: A study of active injection drug users in seven United States metropolitan areas. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 18 Suppl 1 (1998) S30-S36
14. Groseclose S.L., Weinstein B., Jones T.S., Valleroy L.A., Fehrs L.J., and Kassler W.J. Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers-Connecticut, 1992-1993. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 10 (1995) 82-89
15. Hartel D.M., Schoenbaum E.E., Selwyn P.A., Friedland G.H., Klein R.S., and Drucker E. Patterns of heroin, cocaine and speedball injection among Bronx (USA) methadone maintenance patients: 1978-1988. Addiction Research 8 (1997) 394-404
16. Latkin C.A., and Vlahov D. Socially desirable response tendency as a correlate of accuracy of self-reported HIV serostatus for HIV seropositive injection drug users. Addiction 93 (1998) 1191-1197
17. Lurie P., Jones T.S., and Foley J. A sterile syringe for every drug user injection: How many injections take place annually, and how might pharmacists contribute to syringe distribution?. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 18 Suppl 1 (1998) S45-S51
18. Nadelmann E.A., and McNeely J. Doing methadone right. The Public Interest 123 (1996) 83-93
19. National Commission on AIDS. Full report: The twin epidemics of substance use and HIV (1991), US National Commission on AIDS, Washington, DC
20. National Institutes of Health. Consensus development statement. Interventions to prevent HIV risk behaviors, February 11-13, 1997. Available at: (2004). consensus.nih.gov/cons/104/104_statement.htm Accessed March 9
21. In: Normand J., Vlahov D., and Moses L.E. (Eds). Preventing HIV transmission: The role of sterile needles and bleach (1995), National Academy Press, Washington, DC
22. Pouget E.R., Deren S., et al. Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. Journal of Acquired Immune Deficiency Syndromes 39 (2005) 471-477
23. Reily E., Beilenson P., Vlahov D., Smith L., Koenig M., Jones T.S., et al. Operation red box: A pilot project of needle and syringe drop boxes for injection drug users in East Baltimore. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 18 Suppl 1 (1998) S120-S125
24. Remis R.S., Bruneau J., and Hankins C.A. Enough sterile syringes to prevent HIV transmission among injection drug users in Montreal?. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 18 Suppl 1 (1998) S57-S59
25. Schechter M.T., et al. Do needle exchange programs increase the spread of HIV infection among drug users?: An investigation of the Vancouver outbreak. AIDS 13 (1999) F45-F51
26. Schoenbaum E.E., Hartel D.M., and Gourevitch M.N. Needle exchange use among a cohort of injecting drug users. AIDS 10 (1996) 1729-1734
27. Springer K.W., Sterk C.E., Jones T.S., and Friedman L. Syringe disposal options for injection drug users: A community-based perspective. Substance Use and Misuse 34 (1999) 1917-1934
28. Strathdee S.A., et al. Needle exchange is not enough: Lessons from the Vancouver injecting drug use study. Acquired Immune Deficiency Syndrome 11 (1997) F59-F65
29. U.S. Department of Health and Human Services, and Public Health Service. HIV prevention bulletin: Medical advice for persons who inject illicit drugs. May 9, 1997. Available at: (2004). www.cdc.gov/idu/pubs/hiv_prev.htm Accessed March 9
30. Update: Syringe Exchange Programs-United States, 2002. Morbidity and Mortality Weekly Report (MMWR). 2005 Jul 15;54:673-676.
31. Vlahov D. Role of needle exchange programs in AIDS prevention. National Institutes of Health Consensus Development Conference on Interventions to Prevent HIV Risk Behaviors, Program and Abstracts. NIH Consensus Development Conference, February 11-13, 1997. Available at: (2004). http://consensus.nih.gov/1997/1997PreventHIVRisk104html.htm Accessed May 12